All Updates

All Updates

icon
Filter
Product updates
Teladoc Health faces class action lawsuit for allegedly misleading investors
Telehealth
Jun 7, 2022
This week:
Product updates
ABL Space Systems' RS1 rocket damaged during preflight testing
Space Travel and Exploration Tech
Yesterday
Product updates
Partnerships
Meta introduces Llama 3.1, its biggest open AI model yet
Machine Learning Infrastructure
Yesterday
Product updates
Partnerships
Meta introduces Llama 3.1, its biggest open AI model yet
Foundation Models
Yesterday
Management news
Cohere lays off 20 employees after USD 500 million funding round
Foundation Models
Yesterday
Management news
OpenAI reassigns AI safety executive Aleksander Madry to AI reasoning role
Foundation Models
Yesterday
Funding
Bitlayer raises USD 11 million in Series A funding to expand ecosystem
Decentralized Finance (DeFi)
Yesterday
Funding
Harvey raises USD 100 million in Series C funding to expand team and develop products
Generative AI Applications
Yesterday
Product updates
xAI to reportedly release Grok 2 and Grok 3 AI models
Generative AI Applications
Yesterday
Product updates
Adobe releases new Firefly AI tools for Illustrator and Photoshop
Generative AI Applications
Yesterday
Product updates
SensiML launches open-source initiative Piccolo AI for intelligent Edge solutions
Machine Learning Infrastructure
Yesterday
Jun 7, 2022

Teladoc Health faces class action lawsuit for allegedly misleading investors

Product updates

  • A class action lawsuit has been filed against leading telehealth provider Teladoc Health, alleging it has misled investors by mainly not disclosing the industry's intense competition and providing unsustainable revenue and EBITDA targets for FY 2022.

  • The suit was filed on behalf of investors who purchased the company's shares between October 2021 and April 2022 and alleges that the firm and its C-suite executives, mainly the CEO Jason Gorevic and CFO Mala Murthy, are responsible for this violation of the Securities Exchange Act of 1934.

  • This lawsuit comes after Teladoc posted a loss per share of USD 41.58 for Q1 2022 compared to a loss of USD 1.31 in Q1 2021, missing analyst consensus of USD 0.56. The company also revised its estimate for FY2022, projecting revenue growth of 18.1%–23.0% YoY (compared to previous estimates of 25.5%–30.4% growth), mainly due to increased competition in its mental health and chronic care operations. Teladoc’s share fell more than 40% after the earnings release to close at USD 33.51 on April 28, 2022.

  • The lawsuit states that the plaintiff had experienced significant losses and damages due to the wrongful acts and omissions by the named parties. However, a spokesperson for Teladoc Health stated that there was no factual basis for the suit.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.